The lipophilic properties of angiotensin I-converting enzyme inhibitors do not influence their diffusion through cultured endothelium

Japanese Journal of Pharmacology

Volumn 81, Issue 4, 1999, Pages 346-352

  Raasch, Walter ^a   Dendorfer, Andreas ^a   Ball, Benedikt ^a   Dominiak, Peter ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ACE inhibitor; Angiotensin I converting enzyme (ACE); Endothelium; Lipophilic property; Membrane penetration

Indexed keywords

1' [N (1 CARBOXY 3 PHENYLPROPYL)ALANYL]SPIRO[BICYCLO[2.2.2]OCTANE 2,3' PYRROLIDINE] 5' CARBOXYLIC ACID]; 1' [N (1 CARBOXY 3 PHENYLPROPYL)ALANYL]SPIRO[BICYCLO[2.2.2]OCTANE 2,3' PYRROLIDINE] 5' CARBOXYLIC ACID] 1 ETHYL ESTER; CAPTOPRIL; CERANAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRILAT; FOSINOPRIL; FOSINOPRILAT; PERINDOPRIL; PERINDOPRILAT; PRODRUG; QUINAPRIL; QUINAPRILAT; RAMIPRIL; RAMIPRIL OCTYL ESTER MALEATE; RAMIPRILAT; ZOFENOPRIL; ZOFENOPRILAT;

ANIMAL CELL; AORTA; ARTICLE; CONTROLLED STUDY; COW; DIFFUSION; DIFFUSION COEFFICIENT; DRUG ABSORPTION; DRUG RECEPTOR BINDING; ENDOTHELIUM; LIPOPHILICITY; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; NONHUMAN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, THORACIC; CATTLE; CELLS, CULTURED; CHEMISTRY, PHYSICAL; DIFFUSION; ENDOTHELIUM, VASCULAR; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; LIPIDS; PRODRUGS;

EID: 0033369792     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.81.346     Document Type: Article

References (21)

1. Salvetti A: Newer ACE inhibitors. A look at the future. Drugs 40, 800-828 (1990)
2. Pellacani A, Brunner HR and Nussberger J: Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. J Clin Sci 87, 567-574 (1994)
3. Distler A, Liebau H and Wolff HP: Action of angiotensin on sympathetic nerve endings in isolated blood vessels. Nature 207, 764-765 (1965)
4. Inagami T, Okamura T, Clemens D, Celio MR, Naruse K and Naruse M: Local generation of angiotensin in the kidney and in tissue culture. Clin Exp Hypertens [A] 5(7-8), 1137-1149 (1983)
5. Dzau VJ: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77, Suppl 1, 4-13 (1988)
6. Hansch C and Fujita T: ρ-σ-π analysis: a method for the correlation of biological activity and their chemical structure. J Am Chem Soc 86, 1616-1626 (1964)
7. Leo A, Hansch C and Elkins D: Partion coefficients and their uses. Chem Rev 71, 525-616 (1971)
8. Borchardt RT: Assessment of transport barriers using cell and tissue culture systems. Drug Dev Int 16, 2595-2612 (1990)
9. Gudgeon JR and Martin W: Modulation of arterial endothelial permeability: studies on an in vitro model. Br J Pharmacol 98, 1267-1274 (1989)
10. Due LNC and Brunner HR: Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor. Am J Cardiol 70, 27D-34D (1992)
11. Bünning P: Inhibition of angiotensin converting enzyme by 2-[N-(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S, 3S, 5S)-2-azabicyclo[3.3.0]octane-3-carboxylic acid (HOE498 diacid): comparison with captopril and enalaprilat. Drug Res 34, 1406-1410 (1984)
12. Cushman DW, Wang FL, Fung WC, Grover GJ, Harvey CM, Scalese RJ, Mitch SL and DeForrest JM: Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE). Br J Clin Pharmacol 28 Suppl 2, 115S-130S (1989)
13. Lilly LS, Pratt RE, Alexander RW, Larson DM, Ellison KE, Gimbrone MA and Dzau VJ: Renin expression by vascular endothelial cells in culture. Circ Res 57, 312-318 (1984)
14. Hirsch AT, Talsness CE, Schunkert H, Paul M and Dzau VJ: Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 69, 475-482 (1991)
15. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS and Lorell BH: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation. J Clin Invest 86, 1913-1920 (1990)
16. Dzau VJ: Implications of local angiotensin production in cardiovascular physiology and pharmacology. Am J Cardiol 59, 59A-65A (1987)
17. Pipilli E, Manolopoulus VG, Catravas JD, Maragoudakis ME: Angiotensin converting enzyme activity is present in the endothelium-denuded aorta. Br J Pharmacol 98, 333-335 (1989)
18. Lindpaintner K and Ganten D: The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 68, 905-921 (1991)
19. Raasch W, Häuser W, Dendorfer A, Schlecht T, Schwartz C, Fitschen M and Dominiak P: Modulation of myocardial and vascular hypertrophy of SHR by various ACE-inhibitors. Naunyn Schmiedebergs Arch Pharmacol 355, Suppl R76 (1997)
20. Gohlke P, Unger T and Bünning P: Distribution of the angiotensin converting enzyme inhibitor ramiprilat in the blood cell wall. Pharm Pharmacol Lett 2, 66-69 (1992)
21. Dejana E, Corada M and Lampugnani MG: Endothelial cell-to-cell junctions. FASEB J 9, 910-918 (1995)